D
Cullinan Therapeutics, Inc. CGEM
$9.07 $0.111.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 55.21M 54.02M 50.10M 47.73M 44.18M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 208.93M 196.92M 187.36M 183.30M 170.88M
Operating Income -208.93M -196.92M -187.36M -183.30M -170.88M
Income Before Tax -178.62M -167.46M -159.61M -158.24M -148.42M
Income Tax Expenses 117.00K 117.00K -14.12M -14.12M -14.12M
Earnings from Continuing Operations -178.74 -167.58 -145.49 -144.11 -134.30
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 0.00 192.00K 1.95M 1.95M 1.95M
Net Income -178.74M -167.38M -143.54M -142.16M -132.35M
EBIT -208.93M -196.92M -187.36M -183.30M -170.88M
EBITDA -208.62M -196.61M -187.05M -182.99M -170.57M
EPS Basic -3.10 -3.14 -2.88 -3.10 -3.14
Normalized Basic EPS -1.93 -1.96 -1.99 -2.12 -2.15
EPS Diluted -3.10 -3.14 -2.88 -3.10 -3.14
Normalized Diluted EPS -1.93 -1.96 -1.99 -2.12 -2.15
Average Basic Shares Outstanding 230.87M 214.98M 199.19M 183.59M 168.49M
Average Diluted Shares Outstanding 230.87M 214.98M 199.19M 183.59M 168.49M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --